Study Status: RECRUITING
Recruit Status: RECRUITING
Study Type: INTERVENTIONAL
Official Title: Detoxification of the Liver in Primary Sclerosing Cholangitis
Brief Summary: This study is a clinical trial being done to investigate the efficacy of drug BRS201 as a treatment in patients with primary sclerosing cholangitis.
Participation in this study will take 8 weeks long and the study is structured as a cross-over study in which participants will take the study drug for 4 weeks and a placebo drug for 4 weeks in a randomized order in the form of an oral medication.
Participation may also involve receiving an IV dose of the medication.
The study will require participants to attend 9 study visits, all of which will be remote.
Participation will involve taking an oral medication twice daily, tracking the medication in a log, and getting blood drawn and giving a stool sample for a few lab tests throughout the study.
For the lab tests, a research nurse will visit the participant in-home for the convenience of the participant.